Investor Presentation

Summary by AI ^BETAClose X

Roquefort Therapeutics plc announced that following shareholder approval of the acquisition of the exclusive worldwide licence of AO-252 from Coiled Therapeutics, Inc. and the subsequent name change to Coiled Therapeutics plc, effective March 27, 2026, the leadership team will host a live investor presentation on Monday, March 30, 2026, at 2:00 PM BST. The presentation will cover the acquisition and name change, and investors are encouraged to pre-submit questions.

Disclaimer*

Roquefort Therapeutics PLC

26 March 2026

Roquefort Therapeutics plc

("Roquefort Therapeutics" or the "Company")

Investor Presentation

Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company, announces that following the General Meeting held earlier today at which shareholders approved the acquisition of the exclusive worldwide licence of AO-252 from Coiled Therapeutics, Inc. and the name change to Coiled Therapeutics plc, effective 27 March 2026, the leadership team will host a live interactive presentation on the Engage Investor platform, on Monday 30 March 2026, at 2:00pm BST.

Dr Sotirios Stergiopoulos, Chairman Coiled Therapeutics and Sridhar Vempati, CEO Coiled Therapeutics (together with Stephen West, current Chairman of Roquefort Therapeutics) will present.

The Company welcomes all current shareholders and interested investors to join, and encourages investors to pre-submit questions. Investors can also submit questions at any time during the live presentation.

Investors can sign up to Engage Investor at no cost and follow the Company from their personalised investor hub, and can register interest in this event here:

https://engageinvestor.news/ROQ_IP_0326

-ENDS-

Enquiries:

Roquefort Therapeutics plc

Stephen West (Chairman)

+44 (0)20 3918 8633

SP Angel Corporate Finance LLP (Joint Broker)

David Hignell / Adam Cowl / Devik Mehta (Corporate Finance)

Vadim Alexandre / Rob Rees (Corporate Broking)

+44 (0)20 3470 0470

Shard Capital Partners LLP (Joint Broker)

Damon Heath

CPS Capital Group Pty Ltd (Joint Broker)

Jason Peterson / David Valentino

+44 (0)20 4530 6926

+61 (0)8 9223 2222

Burson Buchanan (Public Relations)

Henry Harrison Topham / Jamie Hooper / Toto Berger

+44 (0)20 7466 5000

LEI: ‎254900P4SISIWOR9RH34

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END